BOLD BlogNews and views from Cavidi

Keep in touch

Join our mailing list to receive new information relating to biomarker discovery and detection.

BOLD Amplification Webinar

Exazym®: New Detection Limits Open New Possibilities

Exazym® — Pixels to Proteins

Exazym® — Ultra-Sensitivity Meets Practicality

Exazym® — A Breakthrough in Precision Health

Olof Larsson joins Cavidi as R&D Director

Olof has an academic background with a Ph.D. Pharmacology and a ...

Continue reading

COVID-19 and HIV how we can learn from pandemics

In times of uncertainty and crisis, clear information saves live...

Continue reading

Walter Campos MBA, MSc, PhD Virology has been promoted to Commercial Director, Africa

Walter Campos MBA, MSc, PhD Virology has been promoted to Commer...

Continue reading

Cavidi secures ALMI grant to expand presence in US market

The gene therapy market in the United States is growing rapidly,...

Continue reading

Cavidi finalists in Uppsala Innovation Award 2018

"It was an honour to be nominated especially when one sees the v...

Continue reading

Cavidi an HIV diagnostics industry leader sets sights on virus containment

The Human Immunodeficiency Virus (HIV) has puzzled scientist aro...

Continue reading
Close Menu
×
×

Cart